Richard A. Fair

2018

In 2018, Richard A. Fair earned a total compensation of $3.3M as President and Chief Executive Officer at BELLICUM PHARMACEUTICALS.

Compensation breakdown

Non-Equity Incentive Plan$280,347
Option Awards$2,429,201
Salary$551,050
Other$17,527
Total$3,278,125

Fair received $2.4M in option awards, accounting for 74% of the total pay in 2018.

Fair also received $280.3K in non-equity incentive plan, $551.1K in salary and $17.5K in other compensation.

Rankings

In 2018, Richard A. Fair's compensation ranked 3,509th out of 14,244 executives tracked by ExecPay. In other words, Fair earned more than 75.4% of executives.

ClassificationRankingPercentile
All
3,509
out of 14,244
75th
Division
Manufacturing
1,295
out of 5,765
78th
Major group
Chemicals And Allied Products
454
out of 2,128
79th
Industry group
Drugs
374
out of 1,817
79th
Industry
Pharmaceutical Preparations
287
out of 1,391
79th
Source: SEC filing on April 27, 2020.

Fair's colleagues

We found two more compensation records of executives who worked with Richard A. Fair at BELLICUM PHARMACEUTICALS in 2018.

2018

Shane Ward

BELLICUM PHARMACEUTICALS

Secretary

2018

Alan Smith

BELLICUM PHARMACEUTICALS

Executive Vice President, Technology Operations

News

In-depth

You may also like